Millennium co-founder ventures into epigenetics-based drugs

04/29/2008 | Boston Globe (tiered subscription model), The

Mark Levin, co-founder and board member of Millennium Pharmaceuticals, hopes to replicate the success of the Cambridge, Mass.-based biotech firm at his new venture, Constellation Pharmaceuticals. The startup company aims to develop cancer drugs through epigenetics -- the study of how to switch genes on and off without affecting the underlying DNA sequence.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD